High-dose intravenous immunoglobulins: a promising therapeutic approach for idiopathic systemic capillary leak syndrome

BMJ Case Rep. 2011 May 3:2011:bcr1220103599. doi: 10.1136/bcr.12.2010.3599.

Abstract

The systemic capillary leak syndrome (SCLS), also known as Clarkson's disease, is a life-threatening disorder of unknown cause. It is characterised by recurrent acute episodes of hypotension, weight gain and generalised oedema with haemoconcentration and hypoproteinaemia caused by paroxysmal capillary hyperpermeability with a shift of plasma fluid from the intravascular to the interstitial space. We report the case of a 40-year-old woman with chronic SCLS treated with high-dose intravenous immunoglobulins, after a prophylactic therapy with theophylline and terbutaline was poorly tolerated and failed to decrease the frequency and severity of the attacks sufficiently.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Capillary Leak Syndrome / drug therapy*
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulins, Intravenous / administration & dosage
  • Immunoglobulins, Intravenous / therapeutic use*
  • Treatment Outcome

Substances

  • Immunoglobulin G
  • Immunoglobulins, Intravenous